About FHC
FHC is a company based in Bowdoinham (United States) founded in 1970 by Fred Haer. FHC has completed 2 acquisitions, including Atanse and Neuralynx. FHC offers products and services including Guideline Neuromodulation System, microTargeting Microelectrodes, STarFix Stereotactic Platforms, and WayPoint Navigator. FHC operates in a competitive market with competitors including Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.
Products & Services of FHC
FHC offers a comprehensive portfolio of products and services, including Guideline Neuromodulation System, microTargeting Microelectrodes, STarFix Stereotactic Platforms, and WayPoint Navigator.
Device for precise targeting in clinical and research applications.
Microelectrodes used for brain stimulation therapies.
Platforms for surgical planning and neuromodulation procedures.
System for intraoperative neurophysiological monitoring.
Funding Insights of FHC
- Total Rounds 3
- Last Round Grant — $202,186
- First Round $742,058
(Sep 2008)
- Investors Count 1
All 3 funding rounds of FHC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in FHC
FHC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for FHC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FHC
14 people are tracked at FHC (5 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Fred Haer | Founder & CEO | Leadership |
Andrei Barborica | Vice President FHC Europe; CTO Fhc, Inc. | Leadership |
Cosmin Serban | Chief Executive Officer | Leadership |
Mike Graffam | Director Of Business Transformation Initiatives | Leadership |
Melanie Cooper | President | Leadership |
Stefania Teleru | Regulatory Affairs Specialist - FHC Europe | Team |
Hamed Malekmakan | Embedded Products Engineer - FHC Europe | Team |
Nick Mott | Regional Development Manager | Team |
Zachary Bennett | IT & Security Manager | Team |
Bianca Ignat | Sales And Marketing Specialist - FHC Europe | Team |
David Roy | Senior System Administrator | Team |
Brian Schlick | Junior System Administrator | Team |
Cody Bailey | Database Architect | Team |
Andrei Solomon | Software Engineer - FHC Europe | Team |
Complete people profiles for FHC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FHC
FHC has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Atanse and Neuralynx.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Neuroscience electrophysiology systems are developed for signal analysis and research. | neuralynx.com | Bozeman, United States | 1993 | Dec 2021 | •••• | |
Neurosurgical instruments | atanse.com | Belmont, United States | 2010 | Jan 2018 | •••• |
Complete acquisition details for FHC
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of FHC
FHC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Bruker, Blackrock Neurotech and Esco Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| beckman.com | 1935 | Brea, United States | – | – | Provider of products for biomedical testing for R&D, diagnostic and commercial applications | |
| bruker.com | 1960 | United States | – | 9,707 | Diversified research instrument systems are manufactured and supplied. | |
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| escolifesciences.com | 1978 | Singapore | $400M | – | Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | |
| agilent.com | 1995 | Santa Clara, United States | – | 121 | Diversified instruments are developed for scientific and laboratory management. | |
| unchainedlabs.com | 2015 | Pleasanton, United States | $111M | – | Multiplex protein stability platform for biologics is developed. | |
| waters.com | 1958 | Milford, United States | – | 9,341 | Provider of laboratory management system for researchers and clinicians | |
| sartorius.com | 1870 | Gottingen, Germany | – | 566 | Laboratory and biopharmaceutical equipment is developed for production processes. | |
| fluidigm.com | 1999 | San Francisco, United States | $40.53M | 205 | Instruments for life sciences research and applications are developed. |
Detailed competitors of FHC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of FHC
The website of FHC (fh-co.com) receives about 10.1K visits a month.
- Monthly visits10.1K
▲ 13.2% vs previous month
Websites whose visitors overlap most with FHC. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lafayetteinstrument.com | 100% | 4.1K | #4,562,172 | View details | |
| kationscientific.com | 85% | 1.3K | #13,935,394 | View details | |
| tedpella.com | 76% | – | #469,746 | View details | |
| biocompare.com | 76% | 244.1K | #187,636 | View details | |
siskiyou.com | siskiyou.com | 65% | – | #2,670,348 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for FHC
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to FHC
10 companies that operate in the same segment as FHC (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about FHC
FHC was founded in 1970 and raised its 1st funding round 38 years after it was founded.
FHC is headquartered in Bowdoinham, United States. It is registered at Bowdoinham, Maine, United States.
Fred Haer is the current CEO of FHC. They have also founded this company.
Instruments, systems, and consumables for neurological therapies including deep brain stimulation, ablation, and resection are developed and commercialized by FHC, founded in 1970 and based in Bowdoinham, United States. Applications target movement disorders such as Parkinsons Disease, Epilepsy, Dystonia, and Essential Tremor. Products encompass stereotaxy systems, microelectrodes, positioning systems, recordingstimulation systems, and tissue slicers within the medical devices sector.
FHC's top competitors include Cepheid, Blackrock Neurotech and Agilent.
FHC offers Guideline Neuromodulation System, microTargeting Microelectrodes, STarFix Stereotactic Platforms, and WayPoint Navigator.
FHC has 1 investor. Key investors include HHS.
FHC operates through Fhc, Inc..